Martell Bridget A — SEC insider filings

SEC reporting owner CIK 1629627. 18 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-12-15 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
DELCATH SYSTEMS, INC. (DCTH)Director4—2 legs · 22,500 sh · $488,5085
Aligos Therapeutics, Inc. (ALGS)Director7——8
ACHIEVE LIFE SCIENCES, INC. (ACHV)Director5——5
POINT Biopharma Global Inc. (PNT)Director1——1
Kura Oncology, Inc. (KURA)Acting Chief Medical Officer1———

Insider filings — Martell Bridget A

FiledFormIssuerReported transactionsSource
2026-11-134DELCATH SYSTEMS, INC. (DCTH)Option exercise (M): 22,500 @ $7.85 · Sale (S): 20,570 @ $21.66 · Sale (S): 1,930 @ $22.26 · Option exercise (M): 22,500 (derivative) @ $0EDGAR
2026-06-294Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 5,860 (derivative) @ $0EDGAR
2026-05-144DELCATH SYSTEMS, INC. (DCTH)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-264Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 5,860 (derivative) @ $0EDGAR
2025-06-104ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 31,500 (derivative) @ $0EDGAR
2025-05-194DELCATH SYSTEMS, INC. (DCTH)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2024-06-284Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-284DELCATH SYSTEMS, INC. (DCTH)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2024-02-284Aligos Therapeutics, Inc. (ALGS)Disposition to issuer (D): 30,000 (derivative) @ $0 · Grant/award (A): 8,823 (derivative) @ $0EDGAR
2024-01-294ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 31,500 (derivative) @ $0EDGAR
2023-07-214Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-06-144POINT Biopharma Global Inc. (PNT)Grant/award (A): 80,503 (derivative) @ $0EDGAR
2023-06-094ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 31,500 (derivative) @ $0EDGAR
2022-06-274Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-014ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 4,400 (derivative) @ $0EDGAR
2021-11-184Aligos Therapeutics, Inc. (ALGS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-03-174ACHIEVE LIFE SCIENCES, INC. (ACHV)Grant/award (A): 5,650 (derivative) @ $0EDGAR
2020-12-154Kura Oncology, Inc. (KURA)Holdings only — no transactions reportedEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1629627 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs